Serum fibroblast growth factor 21 levels are related to subclinical atherosclerosis in patients with type 2 diabetes

BACKGROUND: Fibroblast growth factor 21 (FGF21), a glucose and lipid metabolic regulator, has recently been demonstrated to be associated with cardiovascular diseases (CVD) such as carotid atherosclerosis, coronary heart disease and carotid artery plaques. However, the relationship between circulati...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Cardiovasc Diabetol
Egile Nagusiak: Xiao, Yang, Liu, Lingjiao, Xu, Aimin, Zhou, Pengcheng, Long, Zhaofeng, Tu, Yiting, Chen, Xiaoyan, Tang, Weili, Huang, Gan, Zhou, Zhiguang
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2015
Gaiak:
Original Investigation
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4475300/
https://ncbi.nlm.nih.gov/pubmed/26047614
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12933-015-0229-9
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak